New Efforts to Make Cell Therapies Like CAR-T More Accessible for Patients
Cell therapies like CAR-T are an extraordinary new class of drugs that have the potential to successfully treat cancer.
. Last modified on : Dec 01 2023The Evidence House: Valuing What the Physician Sees in Practice
Interpreting study results involves assessing the trade-offs between highly controlled situations and relevance to real life, then using the evidence that makes the most sense in the situation.
. Last modified on : Dec 27 2023Why Randomized Controlled Trials Don’t Always Tell the Real-World Story
RCTs are not always the best approach to get definitive answers to clinical questions.
. Last modified on : Dec 27 2023Complementary Therapies and Cancer: How Much Evidence Is Enough?
We view the use of science-informed, low-risk, affordable therapies as a reasonable option for patients. Stronger evidence of benefit is needed for therapies that are risky, expensive, or otherwise burdensome.
. Last modified on : Dec 27 2023Understanding Research Studies
Evidence that a therapy “works” runs a whole range from unreliable to trustworthy. In this post, we consider the design of research studies.
. Last modified on : Dec 27 2023CancerChoices Complementary Therapy Reviews: Top-Rated on Quality and Trustworthiness
We received the highest rating among the sites evaluated for quality and trustworthiness of information on cancer complementary therapies, with a total score of 4.9/5.
. Last modified on : Dec 27 2023Vitamin D: Hit the Sweet Spot to Reduce Cancer Risk
Evidence so far shows a lower risk of many types of cancer among people with mid-range blood vitamin D levels compared to low levels. However, if your blood level is already in the middle range, taking vitamin D supplements might not bring much benefit regarding cancer risk.
. Last modified on : Dec 27 2023SIO & ASCO Collaborate on Clinical Practice Guidelines
The collaboration represents the deepening fusion of conventional and integrative oncology.
. Last modified on : Dec 27 2023Reflections from a Breast Surgeon with Breast Cancer on How to Improve Cancer Care
It was only when I was diagnosed in 2015 with stage 3 breast cancer that I realised how little I actually knew, and how ill-prepared many patients are to face the hurdles in front of them.
. Last modified on : Dec 27 2023Reducing Cancer Risks and Improving Outcomes
Addressing risk factors collectively as individuals, families, and communities, and also through public policy will have the greatest benefits.
. Last modified on : Dec 27 2023